Back to ATNM

Actinium Pharmaceuticals, Inc. 8-K

Accession 0001213900-20-038523

Filing information

CIK
0001388320
Report date
2020-11-18
Filing date
2020-11-20
Form
8-K
Primary document
ea130223-8k_actiniumpharm.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.